Euroasian Journal of Hepato-Gastroenterology

Register      Login

VOLUME 6 , ISSUE 1 ( January-June, 2016 ) > List of Articles

CASE REPORT

A Hepatocellular Carcinoma Case in a Patient Who had Immunity to Hepatitis B Virus Earlier

İhsan Ates, Mustafa Kaplan, Selim Demirci, Emin Altiparmak

Citation Information : Ates İ, Kaplan M, Demirci S, Altiparmak E. A Hepatocellular Carcinoma Case in a Patient Who had Immunity to Hepatitis B Virus Earlier. Euroasian J Hepatogastroenterol 2016; 6 (1):82-83.

DOI: 10.5005/jp-journals-10018-1173

License: CC BY-NC 4.0

Published Online: 01-01-2016


Abstract

Hepatocellular carcinoma (HCC) is the most common malignant tumor of the liver. Hepatitis B virus infection is one of the most important etilogical factors of HCC. In this case report, a patient with HCC previously infected and having ongoing immunity against hepatitis B virus will be discussed.


PDF Share
  1. Muñoz N, Bosch X. Epidemiology of hepatocellular carcinoma. In: Okuda K, Ishak K, editors. Neoplasms of the liver. Tokyo: Springer; 1987
  2. Hepatocellular carcinoma in the world: epidemiologic questions. In: Tabor E, DiBisceglie AM, Purcell RH, editors. Etiology, pathology and treatment of hepatocellular carcinoma in America. Advances in Applied Technology Series, Houston: Gulf; 1991
  3. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004 Nov;127(5):1372-1380
  4. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981 Nov 21;2(8256):1129-1133
  5. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993 Jun 24; 328(25):1797-1801
  6. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol 1994 Oct;17(2):71-91
  7. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liverrelated death. Gastroenterology 2010 May;138(5):1747-1754
  8. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006 Jan 4;295(1):65-73
  9. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma. Gastroenterology 2011 Oct;141(4):1240-1248
  10. Gastroenterology 2012 May;142(5):1140-1149.e3
  11. A long-term followup study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 1994 Apr;106(4): 1000-1005
  12. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology 2010 May;51(5):1531-1537
  13. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist 2010;15 (Suppl 4):14-22
  14. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988 May;61(10):1942-1956
  15. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002 Jul 18;347(3):168-174.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.